Biotech · Private company · Baltimore, MD, US
Sereneuro Therapeutics, Inc.
Track this companyFree. Adds Sereneuro Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- SN102: a Novel Gene Therapy for Trigeminal Neuralgia PainFiscal year 2026 · $338.1KNIH RePORTER 1R43DE035747-01 · fetched Nov 12, 2026